Intranasal immunization with Chlamydia trachomatis, serovar E, protects from a subsequent vaginal challenge with the homologous serovar

Vaccine

Volumn 17, Issue 22, 1999, Pages 2901-2907

  Peterson, Ellena M ^a   You, John Z ^a   Motin, Vladimir ^a   De La Maza, Luis M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chlamydia trachomatis; Genital infection; Immunization

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; SEROVAR E; UNCLASSIFIED DRUG; VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; FEMALE; GENITAL TRACT INFECTION; IMMUNIZATION; INFECTION RESISTANCE; INTRANASAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; VAGINA MUCOSA;

EID: 0033575490     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00131-0     Document Type: Article

References (25)

1. Moulder J., Hatch W.T.P., Kuo C.-C., Schachter J., Storz J. Bergey's manual of systemic bacteriology. Krieg N.R., Holt J.G. Chlamydia Jones, Rake and Stearns 1945, 55. 1984;729-735 The Williams and Wilkins, Baltimore.
2. Schachter J., Dawson C.R. Human chlamydial infections. 1978;PSG Publishing Company, Littleton, MA.
3. Schachter J. Overview of Chlamydia trachomatis infection and the requirements for a vaccine. Rev Infect Dis. 7:1985;713-716.
4. Taylor-Robinson D., Ward M.E. Meheus A., Spier R.E. Vaccines for sexually transmitted diseases. Immunity to chlamydial infection and the outlook for vaccination. 1989;67-85 Butterworths, London.
5. Collier L.H., Blyth W.A. Immunogenicity of experimental trachoma vaccines in baboons. II. Experiments with adjuvants, and tests of cross-protection. J Hygiene. 64:1966;529-544.
6. Collier L.H., Blyth W.A. Immunogenicity of experimental trachoma vaccines in baboons. III. Experiments with inactivated vaccines. J Hygiene. 65:1967;97-107.
7. Grayston J.T., Kim K.S.W., Alexander E.R., Wang S.-P. Nichols R.L. Protective studies in monkies with trivalent and monovalent trachoma vaccines. Trachoma and related disorders caused by chlamydial agents. 1971;377 Excerpta Medica, Amsterdam.
8. Barron A.L., Rank R.G., Moses E.B. Immune response in mice infected in the genital tract with mouse pneumonitis agent. Infect Immun. 44:1984;82-85.
9. Pal S., Fielder T., Peterson E.M., de la Maza L.M. Protection against infertility in a BALB/c mouse salpingitis model by intranasal immunization with the mouse pneumonitis biovar of Chlamydia trachomatis. Infect Immun. 62:1994;3354-3362.
10. Rank R.G., Barron A.L. Humoral immune response in acquired immunity to chlamydial genital infection of female guinea pigs. Infect Immun. 39:1983;463-465.
11. Tuffrey M., Alexander F., Woods C., Taylor-Robinson D. Genetic susceptibility to chlamydia salpingitis and subsequent infertility in mice. J Reprod Fertil. 95:1992;31-38.
12. Su H., Parnell M., Caldwell H.D. Protective efficacy of a parenterally administered MOMP-derived synthetic oligopeptide vaccine in a murine model of Chlamydia trachomatis genital tract infection: serum neutralizing IgG antibodies do not protect against genital tract infection. Vaccine. 13:1995;1023-1032.
13. Tuffrey M., Alexander F., Conlan W., Woods C., Taylor-Robinson D. Heterotypic protection of mice against chlamydial salpingitis and colonization of the lower genital tract with a human serovar F isolate of Chlamydia trachomatis by prior immunization with recombinant serovar L1 major outer-membrane protein. J Gen Microbiol. 138:1992;1707-1715.
14. Peterson E., Zhong G., Carlson E., de la Maza L.M. Protective role of magnesium in the neutralization by antibodies of Chlamydia trachomatis infectivity. Infect Immun. 56:1988;885-891.
15. Tuffrey M., Taylor-Robinson D. Progesterone as a key factor in the development of a mouse model for genital-tract infection with Chlamydia trachomatis. FEMS Microbiol Lett. 12:1981;111-115.
16. Peterson E.M., Cheng X., Motin V., de la Maza L.M. Effect of isotype on the infectivity of Chlamydia trachomatis in a vaginal mouse model. Infect Immun. 65:1997;2693-2699.
17. Peterson E.M., Chen X., Markoff B., Fielder T., de la Maza L.M. Functional and structural mapping of Chlamydia trachomatis species specific major outer membrane epitopes using neutralizing monoclonal antibodies. Infect Immun. 59:1991;4147-4153.
18. Peterson E.M., Oda R., Tse P., Gastaldi C., Stone S., de la Maza L.M. Comparison of a single-antigen microimmunofluorescence assay and inclusion fluorescent-antibody assay for detecting chlamydial antibodies and correlation of the results with neutralizing ability. J Clin Microbiol. 27:1989;350-352.
19. Igietseme J.U., Uriri I.M., Kumar S.N., Ananaba G.A., Ojior O.O., Momodu I A., Candal D.H., Black C.M. Route of infection that induces a high intensity of gamma interferon-secreting T cells in the genital tract produces optimal protection against Chlamydia trachomatis infection in mice. Infect Immun. 66:1998;4030-4035.
20. Tuffrey M., Alexander F., Taylor-Robinson D. Severity of salpingitis in mice after primary and repeated infection with a human strain of Chlamydia trachomatis. J Exp Pathol. 71:1990;403-410.
21. Cotter T.W., Meng Q., Shen Z.-L., Zhang Y.-X., Su H., Caldwell H.D. Protective efficacy of major outer membrane protein-specific immunoglobulin A (IgA) and IgG monoclonal antibodies in a murine model of Chlamydia trachomatis genital tract infection. Infect Immun. 63:1995;4704-4714.
22. Pal S., Theodor I., Peterson E.M., de la Maza L.M. Monoclonal immunoglobulin A antibody to the major outer membrane protein of Chlamydia trachomatis mouse pneumonitis biovar protects against a chlamydial challenge. Vaccine. 15:1997;575-582.
23. Wang S.-P., Grayston J.T. Micro-immunofluorescence serology of Chlamydia trachomatis. de la Maza L.M., Peterson E.M. Medical virology III. 1984;87-118 Elsevier Science Publishing, New York.
24. Rank R.G., Batteiger B.E., Soderberg L.S. Immunization against Chlamydia genital infection in guinea pigs with UV-inactivated and viable Chlamydiae administered by different routes. Infect Immun. 58:1990;2599-2605.
25. Cui Z.-D., Tristram D., LaScolea L.J., Kwiatkowski T., Kopti S., Ogra P.L. Induction of antibody response to Chlamydia trachomatis in the genital tract by oral immunization. Infect Immun. 59:1991;1465-1469.